Related references
Note: Only part of the references are listed.Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
Update on emerging drug therapies for systemic lupus erythematosus
Chi Chiu Mok
EXPERT OPINION ON EMERGING DRUGS (2010)
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael P. Cancro et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Human Genome Sciences trial data wow lupus community
Mark Ratner
NATURE BIOTECHNOLOGY (2009)
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade
Wei Yu Lin et al.
BLOOD (2007)
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS AND RHEUMATISM (2007)
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells
Chingwei V. Lee et al.
BLOOD (2006)
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng et al.
ARTHRITIS AND RHEUMATISM (2006)
Development of glomerulonephritis during anti-TNF-α therapy for rheumatoid arthritis
MB Stokes et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus -: An open-label study
M Aringer et al.
ARTHRITIS AND RHEUMATISM (2004)
B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells
LG Ng et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokine balance in kidney tissue from lupus nephritis patients
WS Uhm et al.
RHEUMATOLOGY (2003)
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
L De Rycke et al.
ARTHRITIS AND RHEUMATISM (2003)
Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis
E Carlson et al.
ARTHRITIS AND RHEUMATISM (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
G-CSF-stimulated neutrophils are a prominent source of functional BLyS
P Scapini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor
D Seshasayee et al.
IMMUNITY (2003)
Systemic lupus erythematosus: a BLySful, yet BAFFling, disorder
W Stohl
ARTHRITIS RESEARCH & THERAPY (2003)
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus
M Aringer et al.
ARTHRITIS RESEARCH & THERAPY (2003)
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus - Longitudinal observations
W Stohl et al.
ARTHRITIS AND RHEUMATISM (2003)
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
MB Litinskiy et al.
NATURE IMMUNOLOGY (2002)
Drug-induced systemic lupus erythematosus associated with etanercept therapy
N Shakoor et al.
LANCET (2002)
TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS
JA Gross et al.
IMMUNITY (2001)
Regulation of the T-independent humoral response by TACI
GU von Bülow et al.
IMMUNITY (2001)
Treatment of murine lupus with cDNA encoding IFN-γR/Fc
BR Lawson et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
R Horai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
AA Bengtsson et al.
LUPUS (2000)
Share Paper
